Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.7B | 9.1B | 8.7B | 7.7B |
Cost of revenue | 2.1B | 4.3B | 3.8B | 3.6B |
Gross profit | 2.6B | 4.8B | 4.8B | 4.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 2.6B | -1.4B | 2.4B | 2.0B |
Other operating expenses | 90.6M | -32.0M | 22.6M | — |
Operating income | -15.0M | 1.5B | 2.4B | 2.2B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 438.9M | -1.0B | 390.5M | 451.1M |
Other income expense | — | — | — | — |
Pretax income | -41.0M | 1.6B | 2.5B | 2.1B |
Tax provision | 267.5M | 608.7M | 789.6M | 201.8M |
Net income | -308.5M | 955.4M | 1.7B | 1.9B |
Basic EPS | -1.0 | — | 5.2 | 6.0 |
Diluted EPS | -1.0 | — | 5.2 | 6.0 |
Basic average shares | 322.5M | — | 322.5M | 322.5M |
Diluted average shares | 322.5M | — | 322.5M | 322.5M |
EBITDA | 1.3B | 1.4B | 3.8B | 3.0B |
Net income from continuing op. | -308.5M | 955.4M | 1.8B | 2.1B |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |